- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02093234
Changing the Healthcare Delivery Model (C4H)
Changing the Healthcare Delivery Model:A Community Health Worker/Mobile Chronic Care Team Strategy
Study Overview
Status
Conditions
Detailed Description
This is a randomized controlled trial comparing 3 strategies to improve wellness behaviors and clinical goals for DM2 Medicaid patients with uncontrolled DM.
- Group 1 will be assisted by the Voxiva Care4Life mobile health disease management program (C4L) provided on the patient's cell phone.
- Group 2 will be assisted by CHWs who are members of the outpatient medical home health team.
- Group 3 will be assisted by both the Voxiva Care4Life mHealth disease management system (C4L) and a CHW.
Hypotheses:
- A patient interactive cell phone disease management system plus a community health worker (CHW) is superior to either a cell phone system or a CHW alone to activate DM2 Medicaid patients to improve a composite of 7 Wellness Behaviors and 6 Clinical Goals.
- A patient interactive cell phone disease management system will activate Medicaid patients with type 2 diabetes (DM2) to improve the composite of 7 wellness behaviors and 6 clinical outcomes by 25% or greater compared to baseline
Expected Outcomes:
Primary outcomes:
- Superior improvement over baseline of the composite of Wellness Behaviors and Clinical Outcomes in the CHW plus C4L group compared to the CHW alone and cell phone alone groups.
- Improvement by 25% or greater over baseline of the composite of Wellness Behaviors and Clinical Outcomes for patients using C4L alone.
Secondary outcomes:
Improvement in both clinical and behavior endpoints. Endpoints to be compared across the three treatment arms include:
- mean HbA1c,
- mean LDLc Cholesterol
- average BP if hypertensive
- Patient distress measured with Fisher Brief Diabetes Distress Screening Instrument
4) Medication adherence measured with Morisky Medication Adherence Survey 5) Healthcare utilization: ER, acute clinic visits, hospitalizations
Anticipated results and impact on healthcare:
Mobile health has great potential to enhance DM2 patient health behaviors and clinical outcomes both alone and, even better, with assistance of a CHW. mHealth systems can be provided to a wide range of urban and rural DM2 patients resulting in an affordable, a more efficient patient-driven/centered health delivery system.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- Medical Faculty Assoc Inc, GWUniv
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 21 to 75 years old
- Medicaid insurance coverage, Medicare insurance coverage or Affordable Health Care Act insurance coverage
- Fluent in English or Spanish and able to read a text message
- Diagnosed with diabetes mellitus type 2 and A1C is > 8%
Acceptable values will be either :
- A1c obtained within one month prior to baseline (as long as there were no diabetes changes made during that month) or
- A new A1c measured at the baseline screening visit.
- Meets < 10 of the wellness behaviors and clinical goals if diagnosed with hypertension Meets < 9 of the wellness behaviors and clinical goals if not diagnosed with hypertension
Exclusion Criteria:
- Stage 5 chronic kidney disease or end stage renal disease on dialysis
- Terminal illness (expected survival of less than one year)
- Severe dementia or uncontrolled mental illness
- Gestational diabetes mellitus
- Use of an insulin pump
- Inability to use a cellular phone
- Unable to use software application on cellular phone
- Pregnant or planning to get pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Mobile health care application
Patients will be assisted with managing their health by a cell phone application used to promote self care for patients with diabetes.
|
mobile health application for cell phones to assist patients in managing their diabetes.
Other Names:
|
Active Comparator: Community Health Worker (CHW)
CHWs assist study patients in managing there health care in various ways.
|
CHWs assist patients in managing their diabetes in various ways.
Other Names:
|
Experimental: CHWs and mobile health care application
Patients will receive assistance in managing their health from both CHWs and the mobile health cell phone application
|
CHWs will assist diabetic patients in managing their health in conjunction with the mobile health care application.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in the Unmet Behaviors/Goals That Were Not Achieved at Year 1
Time Frame: baseline and 1 year
|
The study staff will determine the status of the 13 behaviors/goals for the year prior to study enrollment.
Our primary endpoint will be the mean change after 1 year in number of behaviors/goals met from baseline.
|
baseline and 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Distress From Baseline as Measured With Fisher Brief Diabetes Distress Screening Instrument
Time Frame: Baseline and 1 year
|
Participants completed the Fisher Brief Diabetes Screening Instrument at baseline and after 1 year of intervention. The instrument consists of 4 questions regarding how participants feel about dealing with diabetes. They are answered using a scale that goes from 1-6, 1= not a bother and 6=very bothersome. Range 4-24. Low distress < 12 : moderate / high distress > or = 12. |
Baseline and 1 year
|
Change in Hemoglobin A1C
Time Frame: Baseline and 1 year
|
Change in HbA1c after 1 year from baseline
|
Baseline and 1 year
|
Change in Medication Adherence
Time Frame: baseline and 1 year
|
Medication adherence Improvement from baseline after 1 year as measured by the Morisky Medication Adherence Survey.
Range 1-4 .
1= least adherent , 4= most adherent
|
baseline and 1 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Richard Katz, MD, Medical Faculty Assoc. Inc, GWUniv
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PCORI- IH-1304-6797
- IH-1304-6797 (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Type 2
-
Antonio Di MauroCompletedType-2 DiabetesItaly
-
DiaMedica Therapeutics IncCompletedDiabetes Type 2Netherlands
-
RenJi HospitalUnknownType 2 Diabetes.China
-
University of Erlangen-Nürnberg Medical SchoolCompletedType 2-diabetesGermany
-
Chengdu Brilliant Pharmaceutical Co., Ltd.Not yet recruitingType 2 Diabetes Mellitus
-
Nanjing First Hospital, Nanjing Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Xiangya Hospital of Central South UniversityRecruitingType 2 Diabetes MellitusChina
-
University of Alabama at BirminghamCompletedType 2 Diabetes MellitusUnited States
-
Imperial College LondonAstraZeneca; Huma; North West London Collaboration of CCGs (NWL CCGs); Imperial...CompletedType 2 Diabetes MellitusUnited Kingdom
-
Universiti Sains MalaysiaCompleted
Clinical Trials on mobile health care application
-
Akdeniz UniversityCompletedAdolescent | Asthma in Children | Self Efficacy | Nursing CareTurkey
-
Indiana UniversityNational Cancer Institute (NCI)Not yet recruitingPediatric Cancer
-
Mohd Khairul Zul Hasymi FirdausPrince of Songkla UniversityCompletedDiabetes Mellitus, Type 2Malaysia
-
Far Eastern Memorial HospitalCompleted
-
University of MiamiNational Institute on Drug Abuse (NIDA)Recruiting
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Council for Musculoskeletal HealthRecruiting
-
Women's College HospitalCanadian Institutes of Health Research (CIHR)CompletedUse of Mobile App Home Monitoring After Ambulatory SurgeryCanada
-
Alberta Health Services, CalgaryAlberta Cancer FoundationCompletedBreast Cancer | Gynecologic CancerCanada
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ Transplantation in ChildrenCompletedPediatric Heart Transplantation | Pediatric Heart Transplant Recipients | Pediatric Cardiac TransplantationUnited States
-
San Diego State UniversityRecruitingObesity | Diabetes Mellitus, Type 2United States